Chicago Trust’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $965K | Buy |
1,925
+309
| +19% | +$148K | 0.14% | 150 |
|
|
2026
Q1 | $794K | Sell |
1,616
-286
| -15% | -$155K | 0.13% | 164 |
|
|
2025
Q4 | $1.1M | Buy |
1,902
+45
| +2% | +$25.4K | 0.17% | 107 |
|
|
2025
Q3 | $901K | Sell |
1,857
-59
| -3% | -$27.5K | 0.13% | 148 |
|
|
2025
Q2 | $777K | Buy |
1,916
+655
| +52% | +$274K | 0.11% | 165 |
|
|
2025
Q1 | $627K | Sell |
1,261
-299
| -19% | -$162K | 0.11% | 169 |
|
|
2024
Q4 | $812K | Sell |
1,560
-161
| -9% | -$88.5K | 0.14% | 142 |
|
|
2024
Q3 | $1.06M | Buy |
1,721
+64
| +4% | +$37.9K | 0.18% | 119 |
|
|
2024
Q2 | $916K | Sell |
1,657
-86
| -5% | -$49.3K | 0.19% | 113 |
|
|
2024
Q1 | $1.01M | Sell |
1,743
-197
| -10% | -$111K | 0.21% | 108 |
|
|
2023
Q4 | $1.03M | Sell |
1,940
-279
| -13% | -$135K | 0.23% | 105 |
|
|
2023
Q3 | $1.12M | Sell |
2,219
-207
| -9% | -$110K | 0.28% | 93 |
|
|
2023
Q2 | $1.27M | Sell |
2,426
-56
| -2% | -$30.2K | 0.3% | 85 |
|
|
2023
Q1 | $1.43M | Sell |
2,482
-35
| -1% | -$19.7K | 0.36% | 76 |
|
|
2022
Q4 | $1.39M | Sell |
2,517
-263
| -9% | -$139K | 0.35% | 75 |
|
|
2022
Q3 | $1.41M | Sell |
2,780
-65
| -2% | -$36.4K | 0.37% | 71 |
|
|
2022
Q2 | $1.55M | Sell |
2,845
-327
| -10% | -$180K | 0.39% | 70 |
|
|
2022
Q1 | $1.87M | Sell |
3,172
-845
| -21% | -$485K | 0.4% | 68 |
|
|
2021
Q4 | $2.68M | Sell |
4,017
-200
| -5% | -$125K | 0.53% | 47 |
|
|
2021
Q3 | $2.41M | Buy |
4,217
+380
| +10% | +$209K | 0.53% | 49 |
|
|
2021
Q2 | $1.94M | Buy |
3,837
+1,253
| +48% | +$591K | 0.46% | 64 |
|
|
2021
Q1 | $1.18M | Sell |
2,584
-530
| -17% | -$253K | 0.4% | 69 |
|
|
2020
Q4 | $1.45M | Buy |
3,114
+57
| +2% | +$26.7K | 0.5% | 58 |
|
|
2020
Q3 | $1.35M | Buy |
3,057
+100
| +3% | +$41.3K | 0.56% | 53 |
|
|
2020
Q2 | $1.07M | Buy |
2,957
+197
| +7% | +$66K | 0.47% | 60 |
|
|
2020
Q1 | $782K | Sell |
2,760
-316
| -10% | -$99.6K | 0.4% | 72 |
|
|
2019
Q4 | $1M | Hold |
3,076
| – | – | 0.41% | 66 |
|
|
2019
Q3 | $896K | Hold |
3,076
| – | – | 0.38% | 77 |
|
|
2019
Q2 | $904 | Buy |
3,076
+200
| +7% | +$55.1K | 0.39% | 76 |
|
|
2019
Q1 | $787 | Hold |
2,876
| – | – | 0.34% | 77 |
|
|
2018
Q4 | $644 | Sell |
2,876
-20
| -0.7% | -$4.69K | 0.31% | 89 |
|
|
2018
Q3 | $707K | Sell |
2,896
-50
| -2% | -$11.5K | 0.28% | 88 |
|
|
2018
Q2 | $610K | Sell |
2,946
-1
| -0% | -$212 | 0.26% | 91 |
|
|
2018
Q1 | $609K | Sell |
2,947
-886
| -23% | -$186K | 0.26% | 91 |
|
|
2017
Q4 | $728K | Sell |
3,833
-19
| -0.5% | -$3.64K | 0.29% | 85 |
|
|
2017
Q3 | $729 | Hold |
3,852
| – | – | 0.31% | 85 |
|
|
2017
Q2 | $672 | Hold |
3,852
| – | – | 0.3% | 82 |
|
|
2017
Q1 | $591 | Sell |
3,852
-2,425
| -39% | -$371K | 0.26% | 95 |
|
|
2016
Q4 | $886K | Sell |
6,277
-1,350
| -18% | -$199K | 0.38% | 74 |
|
|
2016
Q3 | $1.21M | Sell |
7,627
-150
| -2% | -$23.1K | 0.53% | 68 |
|
|
2016
Q2 | $1.15M | Sell |
7,777
-20
| -0.3% | -$2.95K | 0.47% | 74 |
|
|
2016
Q1 | $1.1M | Sell |
7,797
-475
| -6% | -$63.7K | 0.46% | 75 |
|
|
2015
Q4 | $1.17M | Hold |
8,272
| – | – | 0.46% | 76 |
|
|
2015
Q3 | $1.01M | Hold |
8,272
| – | – | 0.39% | 82 |
|
|
2015
Q2 | $1.07M | Hold |
8,272
| – | – | 0.38% | 81 |
|
|
2015
Q1 | $1.11M | Buy |
+8,272
| New | +$1.07M | 0.38% | 81 |
|
Other funds holding TMO
LT
CF
SP
DLA
PL
HPC
Chicago Trust's TMO Position: Q2 2026 in Review
Chicago Trust increased its Thermo Fisher Scientific (TMO) stake by 19% in Q2 2026, buying an estimated $148K and bringing the position to 1,925 shares worth $965K. The position accounts for 0.14% of the portfolio, ranked #150.
Chicago Trust first reported a position in TMO in Q1 2015 and has held it in 46 quarters since. The position peaked at $2.68M in Q4 2021. 510 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Chicago Trust held 1,925 shares of Thermo Fisher Scientific worth $965K as of Q2 2026.
- Chicago Trust bought 309 Thermo Fisher Scientific shares in Q2 2026, an estimated $148K.
- Thermo Fisher Scientific made up 0.14% of Chicago Trust's portfolio in Q2 2026, its #150 holding.
- Chicago Trust first reported a position in Thermo Fisher Scientific in Q1 2015 and has held it in 46 quarters since.
- Chicago Trust's Thermo Fisher Scientific position peaked at $2.68M in Q4 2021.
- 510 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Chicago Trust's 13F filing for Q2 2026, filed 16 Jul 2026.